Amgen on Tuesday reported quarterly financial results that beat Wall Street expectations as product sales rose 12%, ...

Vancouver, Canada, November 4th, 2025, FinanceWire USA News Group News Commentary – Healthcare’s embrace of AI is moving from pilot to ...

Sarepta Therapeutics shares plunged 37% after two Duchenne muscular dystrophy drugs failed a key trial, raising regulatory ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

Meet some of the team behind UConn Health's effort to improve health care quality, address patient disparities with more REL ...

Investors are watching for private updates on the job market as the government shutdown is days away from becoming the ...

UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

UTime (WTO) outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial ...

New work requirements are expected to leave millions of poor Americans uninsured. For Equifax, which charges states steep ...

Healthcare stocks in the S&P 500 are up just 4.8% for the year, compared to the S&P 500's 15.9% gain.